Pharming (PHAR) Change in Intangibles (2019 - 2025)
Pharming's (PHAR) quarterly Change in Intangibles came in at -$6000.0 in Q4 2025, little changed YoY from -$6000.0 in Q4 2024, and little changed on a QoQ basis from -$6000.0 in Q4 2024.
Powered by 
Analysis
Pharming (PHAR) Change in Intangibles (2019 - 2025) Analysis & Trends
Pharming (PHAR) has 7 years of Change in Intangibles data on file, last reported at -$6000.0 in Q4 2025.
- Quarterly Change in Intangibles changed 0.0% year-over-year to -$6000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$206000.0 (down 642.11% YoY) and the FY2023 annual result came in at -$27000.0, up 95.51% from the prior year.
- Change in Intangibles held at -$6000.0 in Q4 2025, from -$6000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $238000.0 in Q3 2022 to a low of -$460000.0 in Q4 2021.
- A 5-year average of -$109830.6 and a median of -$27000.0 in 2023 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2021 — Change in Intangibles plunged 4765.84% — and 2022, when it surged 169.83%.
- Tracing PHAR's Change in Intangibles over 5 years: stood at -$460000.0 in 2021, then surged by 63.7% to -$167000.0 in 2022, then jumped by 83.83% to -$27000.0 in 2023, then jumped by 77.78% to -$6000.0 in 2024, then changed by 0.0% to -$6000.0 in 2025.
- The last three Change in Intangibles figures came in at -$6000.0 (Q4 2025), -$6000.0 (Q4 2024), and -$27000.0 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Pharming | 781.07 Mn | 621.57 Mn | 141.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 199,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Dec 31, 2022 | -601,000.00 |
| Sep 30, 2022 | 238,000.00 |
| Dec 31, 2021 | -3.45 Mn |
| Sep 30, 2021 | -340,814.04 |
| Dec 31, 2020 | -9,453.67 |
| Sep 30, 2020 | -119,143.88 |
| Dec 31, 2019 | -1.83 Mn |